Logo image of 6MK.DE

MERCK & CO. INC. (6MK.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:6MK - US58933Y1055 - Common Stock

89.1 EUR
+1.5 (+1.71%)
Last: 12/23/2025, 7:00:00 PM
Fundamental Rating

7

Taking everything into account, 6MK scores 7 out of 10 in our fundamental rating. 6MK was compared to 54 industry peers in the Pharmaceuticals industry. While 6MK has a great profitability rating, there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on 6MK. These ratings would make 6MK suitable for value investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

6MK had positive earnings in the past year.
6MK had a positive operating cash flow in the past year.
Each year in the past 5 years 6MK has been profitable.
Each year in the past 5 years 6MK had a positive operating cash flow.
6MK.DE Yearly Net Income VS EBIT VS OCF VS FCF6MK.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

1.2 Ratios

Looking at the Return On Assets, with a value of 14.69%, 6MK belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
6MK's Return On Equity of 36.71% is amongst the best of the industry. 6MK outperforms 90.74% of its industry peers.
Looking at the Return On Invested Capital, with a value of 12.83%, 6MK is in the better half of the industry, outperforming 64.81% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for 6MK is in line with the industry average of 13.79%.
Industry RankSector Rank
ROA 14.69%
ROE 36.71%
ROIC 12.83%
ROA(3y)9.42%
ROA(5y)9.66%
ROE(3y)23.17%
ROE(5y)26.32%
ROIC(3y)13.67%
ROIC(5y)12.02%
6MK.DE Yearly ROA, ROE, ROIC6MK.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

6MK's Profit Margin of 29.63% is amongst the best of the industry. 6MK outperforms 92.59% of its industry peers.
In the last couple of years the Profit Margin of 6MK has remained more or less at the same level.
6MK has a Operating Margin of 38.08%. This is amongst the best in the industry. 6MK outperforms 90.74% of its industry peers.
6MK's Operating Margin has improved in the last couple of years.
With an excellent Gross Margin value of 78.72%, 6MK belongs to the best of the industry, outperforming 81.48% of the companies in the same industry.
6MK's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 38.08%
PM (TTM) 29.63%
GM 78.72%
OM growth 3Y5.75%
OM growth 5Y7.99%
PM growth 3Y-0.15%
PM growth 5Y1.18%
GM growth 3Y1.92%
GM growth 5Y1.45%
6MK.DE Yearly Profit, Operating, Gross Margins6MK.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 6MK is creating some value.
Compared to 1 year ago, 6MK has about the same amount of shares outstanding.
The number of shares outstanding for 6MK has been reduced compared to 5 years ago.
The debt/assets ratio for 6MK has been reduced compared to a year ago.
6MK.DE Yearly Shares Outstanding6MK.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B
6MK.DE Yearly Total Debt VS Total Assets6MK.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

6MK has an Altman-Z score of 4.09. This indicates that 6MK is financially healthy and has little risk of bankruptcy at the moment.
6MK has a Altman-Z score of 4.09. This is comparable to the rest of the industry: 6MK outperforms 55.56% of its industry peers.
The Debt to FCF ratio of 6MK is 3.17, which is a good value as it means it would take 6MK, 3.17 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.17, 6MK is in the better half of the industry, outperforming 62.96% of the companies in the same industry.
6MK has a Debt/Equity ratio of 0.77. This is a neutral value indicating 6MK is somewhat dependend on debt financing.
6MK's Debt to Equity ratio of 0.77 is in line compared to the rest of the industry. 6MK outperforms 40.74% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 3.17
Altman-Z 4.09
ROIC/WACC1.47
WACC8.72%
6MK.DE Yearly LT Debt VS Equity VS FCF6MK.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

6MK has a Current Ratio of 1.66. This is a normal value and indicates that 6MK is financially healthy and should not expect problems in meeting its short term obligations.
6MK has a Current ratio of 1.66. This is in the better half of the industry: 6MK outperforms 66.67% of its industry peers.
6MK has a Quick Ratio of 1.44. This is a normal value and indicates that 6MK is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of 6MK (1.44) is better than 75.93% of its industry peers.
Industry RankSector Rank
Current Ratio 1.66
Quick Ratio 1.44
6MK.DE Yearly Current Assets VS Current Liabilites6MK.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 48.07% over the past year.
Measured over the past years, 6MK shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.04% on average per year.
Looking at the last year, 6MK shows a small growth in Revenue. The Revenue has grown by 1.68% in the last year.
6MK shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.40% yearly.
EPS 1Y (TTM)48.07%
EPS 3Y6.87%
EPS 5Y8.04%
EPS Q2Q%70.7%
Revenue 1Y (TTM)1.68%
Revenue growth 3Y9.63%
Revenue growth 5Y10.4%
Sales Q2Q%3.72%

3.2 Future

Based on estimates for the next years, 6MK will show a small growth in Earnings Per Share. The EPS will grow by 5.92% on average per year.
6MK is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.39% yearly.
EPS Next Y18.58%
EPS Next 2Y11.48%
EPS Next 3Y11.36%
EPS Next 5Y5.92%
Revenue Next Year1.22%
Revenue Next 2Y3.07%
Revenue Next 3Y3.9%
Revenue Next 5Y2.39%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
6MK.DE Yearly Revenue VS Estimates6MK.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20B 40B 60B
6MK.DE Yearly EPS VS Estimates6MK.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

7

4. Valuation

4.1 Price/Earnings Ratio

6MK is valuated reasonably with a Price/Earnings ratio of 11.93.
6MK's Price/Earnings ratio is a bit cheaper when compared to the industry. 6MK is cheaper than 77.78% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.57. 6MK is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 11.06, the valuation of 6MK can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 6MK indicates a somewhat cheap valuation: 6MK is cheaper than 77.78% of the companies listed in the same industry.
6MK is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.04, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.93
Fwd PE 11.06
6MK.DE Price Earnings VS Forward Price Earnings6MK.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

6MK's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. 6MK is cheaper than 77.78% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of 6MK indicates a somewhat cheap valuation: 6MK is cheaper than 64.81% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 19.98
EV/EBITDA 9.78
6MK.DE Per share data6MK.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
6MK has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)0.64
PEG (5Y)1.48
EPS Next 2Y11.48%
EPS Next 3Y11.36%

6

5. Dividend

5.1 Amount

6MK has a Yearly Dividend Yield of 3.38%. Purely for dividend investing, there may be better candidates out there.
6MK's Dividend Yield is a higher than the industry average which is at 1.85.
6MK's Dividend Yield is rather good when compared to the S&P500 average which is at 1.88.
Industry RankSector Rank
Dividend Yield 3.38%

5.2 History

On average, the dividend of 6MK grows each year by 6.90%, which is quite nice.
Dividend Growth(5Y)6.9%
Div Incr Years8
Div Non Decr Years8
6MK.DE Yearly Dividends per share6MK.DE Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

42.60% of the earnings are spent on dividend by 6MK. This is a bit on the high side, but may be sustainable.
The dividend of 6MK is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP42.6%
EPS Next 2Y11.48%
EPS Next 3Y11.36%
6MK.DE Yearly Income VS Free CF VS Dividend6MK.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B
6MK.DE Dividend Payout.6MK.DE Dividend Payout, showing the Payout Ratio.6MK.DE Dividend Payout.PayoutRetained Earnings

MERCK & CO. INC.

FRA:6MK (12/23/2025, 7:00:00 PM)

89.1

+1.5 (+1.71%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-30 2025-10-30/bmo
Earnings (Next)02-03 2026-02-03/amc
Inst Owners80.3%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap221.15B
Revenue(TTM)64.23B
Net Income(TTM)19.03B
Analysts76.47
Price Target91.55 (2.75%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.38%
Yearly Dividend2.65
Dividend Growth(5Y)6.9%
DP42.6%
Div Incr Years8
Div Non Decr Years8
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.37%
Min EPS beat(2)7.69%
Max EPS beat(2)13.06%
EPS beat(4)4
Avg EPS beat(4)7.28%
Min EPS beat(4)2.93%
Max EPS beat(4)13.06%
EPS beat(8)8
Avg EPS beat(8)21.72%
EPS beat(12)12
Avg EPS beat(12)16.45%
EPS beat(16)16
Avg EPS beat(16)15.36%
Revenue beat(2)1
Avg Revenue beat(2)-0.35%
Min Revenue beat(2)-1.54%
Max Revenue beat(2)0.83%
Revenue beat(4)2
Avg Revenue beat(4)-0.09%
Min Revenue beat(4)-1.54%
Max Revenue beat(4)0.83%
Revenue beat(8)5
Avg Revenue beat(8)0.41%
Revenue beat(12)9
Avg Revenue beat(12)1.14%
Revenue beat(16)13
Avg Revenue beat(16)1.98%
PT rev (1m)5.09%
PT rev (3m)6.81%
EPS NQ rev (1m)-0.28%
EPS NQ rev (3m)-7%
EPS NY rev (1m)0.32%
EPS NY rev (3m)0.61%
Revenue NQ rev (1m)0.09%
Revenue NQ rev (3m)-0.8%
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)0.05%
Valuation
Industry RankSector Rank
PE 11.93
Fwd PE 11.06
P/S 4.06
P/FCF 19.98
P/OCF 15.27
P/B 5.03
P/tB 17.44
EV/EBITDA 9.78
EPS(TTM)7.47
EY8.38%
EPS(NY)8.05
Fwd EY9.04%
FCF(TTM)4.46
FCFY5.01%
OCF(TTM)5.83
OCFY6.55%
SpS21.96
BVpS17.72
TBVpS5.11
PEG (NY)0.64
PEG (5Y)1.48
Graham Number54.58
Profitability
Industry RankSector Rank
ROA 14.69%
ROE 36.71%
ROCE 24.24%
ROIC 12.83%
ROICexc 15.66%
ROICexgc 28.27%
OM 38.08%
PM (TTM) 29.63%
GM 78.72%
FCFM 20.31%
ROA(3y)9.42%
ROA(5y)9.66%
ROE(3y)23.17%
ROE(5y)26.32%
ROIC(3y)13.67%
ROIC(5y)12.02%
ROICexc(3y)15.77%
ROICexc(5y)13.76%
ROICexgc(3y)34.22%
ROICexgc(5y)31.54%
ROCE(3y)25.81%
ROCE(5y)22.7%
ROICexgc growth 3Y7.57%
ROICexgc growth 5Y3.37%
ROICexc growth 3Y15.27%
ROICexc growth 5Y10.69%
OM growth 3Y5.75%
OM growth 5Y7.99%
PM growth 3Y-0.15%
PM growth 5Y1.18%
GM growth 3Y1.92%
GM growth 5Y1.45%
F-Score6
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 3.17
Debt/EBITDA 1.38
Cap/Depr 87.9%
Cap/Sales 6.25%
Interest Coverage 18.43
Cash Conversion 58.79%
Profit Quality 68.56%
Current Ratio 1.66
Quick Ratio 1.44
Altman-Z 4.09
F-Score6
WACC8.72%
ROIC/WACC1.47
Cap/Depr(3y)95.66%
Cap/Depr(5y)110.48%
Cap/Sales(3y)6.36%
Cap/Sales(5y)7.78%
Profit Quality(3y)903.98%
Profit Quality(5y)573.68%
High Growth Momentum
Growth
EPS 1Y (TTM)48.07%
EPS 3Y6.87%
EPS 5Y8.04%
EPS Q2Q%70.7%
EPS Next Y18.58%
EPS Next 2Y11.48%
EPS Next 3Y11.36%
EPS Next 5Y5.92%
Revenue 1Y (TTM)1.68%
Revenue growth 3Y9.63%
Revenue growth 5Y10.4%
Sales Q2Q%3.72%
Revenue Next Year1.22%
Revenue Next 2Y3.07%
Revenue Next 3Y3.9%
Revenue Next 5Y2.39%
EBIT growth 1Y2.78%
EBIT growth 3Y15.93%
EBIT growth 5Y19.23%
EBIT Next Year28.1%
EBIT Next 3Y13.81%
EBIT Next 5Y8.95%
FCF growth 1Y-0.9%
FCF growth 3Y23.27%
FCF growth 5Y12.67%
OCF growth 1Y-0.73%
OCF growth 3Y15.02%
OCF growth 5Y9.82%

MERCK & CO. INC. / 6MK.DE FAQ

Can you provide the ChartMill fundamental rating for MERCK & CO. INC.?

ChartMill assigns a fundamental rating of 7 / 10 to 6MK.DE.


What is the valuation status of MERCK & CO. INC. (6MK.DE) stock?

ChartMill assigns a valuation rating of 7 / 10 to MERCK & CO. INC. (6MK.DE). This can be considered as Undervalued.


What is the profitability of 6MK stock?

MERCK & CO. INC. (6MK.DE) has a profitability rating of 8 / 10.


What is the valuation of MERCK & CO. INC. based on its PE and PB ratios?

The Price/Earnings (PE) ratio for MERCK & CO. INC. (6MK.DE) is 11.93 and the Price/Book (PB) ratio is 5.03.


Can you provide the dividend sustainability for 6MK stock?

The dividend rating of MERCK & CO. INC. (6MK.DE) is 6 / 10 and the dividend payout ratio is 42.6%.